266 related articles for article (PubMed ID: 21554716)
1. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites.
Kraus B; Boller K; Reuter A; Schnierle BS
Retrovirology; 2011 Mar; 8():21. PubMed ID: 21429186
[TBL] [Abstract][Full Text] [Related]
3. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome.
Heslin DJ; Murcia P; Arnaud F; Van Doorslaer K; Palmarini M; Lenz J
J Virol; 2009 Jan; 83(2):1105-14. PubMed ID: 19004950
[TBL] [Abstract][Full Text] [Related]
5. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
6. Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.
Ruprecht K; Ferreira H; Flockerzi A; Wahl S; Sauter M; Mayer J; Mueller-Lantzsch N
J Virol; 2008 Oct; 82(20):10008-16. PubMed ID: 18684837
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and functional characterization of the human endogenous retrovirus K113.
Beimforde N; Hanke K; Ammar I; Kurth R; Bannert N
Virology; 2008 Feb; 371(1):216-25. PubMed ID: 18076964
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
9. The human endogenous retrovirus family HERV-K(HML-3).
Mayer J; Meese EU
Genomics; 2002 Sep; 80(3):331-43. PubMed ID: 12213204
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity.
Monde K; Terasawa H; Nakano Y; Soheilian F; Nagashima K; Maeda Y; Ono A
Retrovirology; 2017 Apr; 14(1):27. PubMed ID: 28446240
[TBL] [Abstract][Full Text] [Related]
11. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain.
Hanke K; Kramer P; Seeher S; Beimforde N; Kurth R; Bannert N
J Virol; 2009 Dec; 83(24):12790-800. PubMed ID: 19812154
[TBL] [Abstract][Full Text] [Related]
13. Sequence variability, gene structure, and expression of full-length human endogenous retrovirus H.
Jern P; Sperber GO; Ahlsén G; Blomberg J
J Virol; 2005 May; 79(10):6325-37. PubMed ID: 15858016
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays.
Kuhelj R; Rizzo CJ; Chang CH; Jadhav PK; Towler EM; Korant BD
J Biol Chem; 2001 May; 276(20):16674-82. PubMed ID: 11278433
[TBL] [Abstract][Full Text] [Related]
15. Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome.
Lavie L; Medstrand P; Schempp W; Meese E; Mayer J
J Virol; 2004 Aug; 78(16):8788-98. PubMed ID: 15280487
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
[TBL] [Abstract][Full Text] [Related]
17. A human endogenous retrovirus encoded protease potentially cleaves numerous cellular proteins.
Rigogliuso G; Biniossek ML; Goodier JL; Mayer B; Pereira GC; Schilling O; Meese E; Mayer J
Mob DNA; 2019; 10():36. PubMed ID: 31462935
[TBL] [Abstract][Full Text] [Related]
18. Development of an antigen-capture ELISA for the detection of the p27-CA protein of HERV-K(HML-2).
Hohn O; Mostafa S; Norley S; Bannert N
J Virol Methods; 2016 Aug; 234():186-92. PubMed ID: 27142113
[TBL] [Abstract][Full Text] [Related]
19. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.
Subramanian RP; Wildschutte JH; Russo C; Coffin JM
Retrovirology; 2011 Nov; 8():90. PubMed ID: 22067224
[TBL] [Abstract][Full Text] [Related]
20. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.
Monde K; Contreras-Galindo R; Kaplan MH; Markovitz DM; Ono A
J Virol; 2012 Oct; 86(20):11194-208. PubMed ID: 22855497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
